REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $652,238 | +10.4% | 6,397 | -1.5% | 0.00% | 0.0% |
Q1 2023 | $590,707 | +194.7% | 6,497 | +23.1% | 0.00% | +200.0% |
Q4 2022 | $200,435 | +77.4% | 5,276 | +17.6% | 0.00% | 0.0% |
Q3 2022 | $113,000 | -17.5% | 4,485 | -0.4% | 0.00% | 0.0% |
Q2 2022 | $137,000 | -11.0% | 4,505 | -4.0% | 0.00% | 0.0% |
Q1 2022 | $154,000 | +24.2% | 4,695 | -0.4% | 0.00% | 0.0% |
Q4 2021 | $124,000 | -73.8% | 4,714 | -0.0% | 0.00% | -66.7% |
Q3 2021 | $474,000 | -23.5% | 4,715 | +7.7% | 0.00% | 0.0% |
Q2 2021 | $620,000 | +144.1% | 4,378 | +71.9% | 0.00% | +50.0% |
Q1 2021 | $254,000 | -27.2% | 2,547 | -9.8% | 0.00% | 0.0% |
Q4 2020 | $349,000 | +39.0% | 2,823 | +9.4% | 0.00% | 0.0% |
Q3 2020 | $251,000 | -37.7% | 2,580 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $403,000 | +59.3% | 2,580 | +47.2% | 0.00% | +50.0% |
Q1 2020 | $253,000 | -7.3% | 1,753 | +31.5% | 0.00% | 0.0% |
Q4 2019 | $273,000 | +173.0% | 1,333 | +7.5% | 0.00% | +100.0% |
Q3 2019 | $100,000 | +6.4% | 1,240 | +25.1% | 0.00% | 0.0% |
Q2 2019 | $94,000 | +10.6% | 991 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $85,000 | +203.6% | 991 | +100.2% | 0.00% | – |
Q4 2018 | $28,000 | -30.0% | 495 | 0.0% | 0.00% | – |
Q3 2018 | $40,000 | – | 495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $295,368,026 | 59.26% |
Ally Bridge Group (NY) LLC | 105,558 | $10,762,694 | 13.04% |
First Light Asset Management, LLC | 1,432,208 | $146,027,928 | 11.44% |
Boxer Capital, LLC | 1,430,004 | $145,803 | 6.76% |
MPM BioImpact LLC | 234,478 | $23,907,377 | 4.81% |
Tri Locum Partners LP | 96,274 | $9,816,097 | 3.65% |
Altium Capital Management LP | 41,485 | $4,229,811 | 3.20% |
Ghost Tree Capital, LLC | 85,000 | $8,666,600 | 2.86% |
KRS Capital Management, LLC | 27,941 | $2,848,864 | 2.85% |
Sofinnova Investments, Inc. | 322,471 | $32,879,143 | 2.15% |